.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Integrating Newer Therapies into Management of Adult ALL

EP. 1: Prognostic Factors Which Impact ALL Management

January 13th 2021

EP. 2: Treating Young Adult Patients With Philadelphia Chromosome–Positive ALL

January 13th 2021

EP. 3: Treating Older Adult Patients With Philadelphia Chromosome-Positive ALL

January 13th 2021

EP. 4: Treating Young Adult Patients With Philadelphia Chromosome-Negative ALL

January 21st 2021

EP. 5: Treating Older Adult Patients With Philadelphia Chromosome-Negative ALL

January 28th 2021

EP. 6: Role of MRD Testing in Acute Lymphoblastic Leukemia

January 28th 2021

EP. 7: Treatment of Acute Lymphoblastic Leukemia in the Community Setting

February 4th 2021

EP. 8: Managing MRD-Positive Acute Lymphoblastic Leukemia

February 4th 2021

EP. 9: Managing MRD-Negative Acute Lymphoblastic Leukemia

February 11th 2021

EP. 10: Role of Transplant in Older Adults With Acute Lymphoblastic Leukemia

February 11th 2021

EP. 11: Approach to Managing Relapsed Acute Lymphoblastic Leukemia

February 18th 2021

EP. 12: CAR T-Cell Therapy After First Relapse of Acute Lymphoblastic Leukemia

February 18th 2021

EP. 13: CAR T-Cell Therapy Use in Second Line Acute Lymphoblastic Leukemia

February 25th 2021

EP. 14: Investigational CAR T-Cell Therapy in Acute Lymphoblastic Leukemia

February 25th 2021

EP. 15: Evolving Field of Acute Lymphoblastic Leukemia

March 4th 2021

EP. 16: ASH Updates for CAR T-Cell Therapy in Acute Lymphoblastic Leukemia

March 4th 2021